Accession Number: | 0001209191-14-055071 |
Date: | 2014-08-27 |
Issuer: | AMICUS THERAPEUTICS INC (FOLD) |
Original Submission Date: |
GERSHKOWITZ JAYNE
1 CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-08-27 | P | 5,000 | a | $7.00 | 55,000 | direct | ||
COMMON STOCK | 2014-08-27 | S | 5,000 | d | $7.00 | 50,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS (RIGHT TO BUY) | 3.32 | 2014-08-27 | deemed execution date | M | 5,000 (d) | 2014-03-01 | 2020-03-16 | common stock 5,000 | $3.32 | 0 | direct |
ID | footnote |
---|---|
f1 | the exercise of stock options and subsequent sale of common stock were made pursuant to a rule 10b5-1 trading plan adopted by the reporting person on march 17, 2014. |